Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis-Reference-Cited by-同舟云学术

Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis

Published:2016-01-17 Issue:S1 Volume:87 Page:624-629
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Xu Bo¹,Qian Jie¹,Ge Junbo²,Wang Jian'an³,Chen Fang⁴,Chen Jiyan⁵,Wei Meng⁶,Chen Yundai⁷,Yang Yuejin¹,Gao Runlin¹,

Affiliation:

1. Fu Wai Hospital; National Center for Cardiovascular Diseases; Beijing China

2. Affiliated Zhongshan Hospital of Fudan University; Shanghai China

3. The Second Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou China

4. Affiliated Anzhen Hospital of Capital Medical University; Beijing China

5. Guangdong General Hospital; Guangzhou China

6. Shanghai Sixth People's Hospital; Shanghai China

7. Chinese PLA General Hospital; Beijing China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26401/fullpdf

Reference13 articles.

1. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: Results from the PEPCAD China ISR trial;Xu;JACC Cardiovasc Interv,2014

2. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial;Byrne;Lancet,2013

3. Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis: 3-year results of a randomized controlled trial;Kufner;JACC Cardiovasc Interv,2015

4. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES study;Rittger;J Am Coll Cardiol,2012

5. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis;Habara;JACC Cardiovasc Interv,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis;Journal of the Society for Cardiovascular Angiography & Interventions;2023-07

2. Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications;Journal of the Society for Cardiovascular Angiography & Interventions;2023-05

3. Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID study;Journal of Cardiology;2023-01

4. Comparing the efficacy and safety of two different drug-coated balloons in in-stent restenosis: Two-year clinical outcomes of the RESTORE ISR China randomized trial;Journal of Cardiology;2023-01

5. Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis;JACC: Asia;2022-04